Health Condition 1: G448- Other specified headache syndromes
Conditions
Interventions
Intervention1: Safuf e Banafsha Tea bags: Formulation:Safuf-e-Banafsha Tea Bags containing:
-Banafsha (Viola odorata) : 4 parts
-Gul-e-Surkh (Rosa damascena) : 2 parts
-Kishniz-e-Khushk (Coriandrum sa
Sponsors
CCRUM
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adults aged 18 60 years diagnosed with Suda Shirki Midi(gastric headache)based on classical Unani criteria. 2.Experiencing recurrent headache episodes attributed to gastric disturbances. 3.Headache severity and frequency significant enough to impact daily activities. 4.Headache presenting with at least two of the following characteristics: .Frontal or upper abdominal referral .Pulsating or pressure-type quality .Moderate to severe intensity .Worsening with routine activity (e.g., head movement, bending) 5.During headache, if there is : .Gastrointestinal discomfort (nausea, vomiting, bloating) .Photophobia or Phonophobia 6.Able and willing to provide written informed consent.
Exclusion criteria
Exclusion criteria: 1. Secondary headaches due to neurological, systemic, or psychiatric disorders. 2.Major medical illness under treatment. 3. Pregnant or lactating women. 4.Known allergy to any ingredients ofSafuf -e-Banafsha Tea bags. 5.History of alcohol & drug abuse . 6.Use of any other alternative medication during study period. 7.Patients with baseline VAS score greater than 7
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in the sign, symptoms and Reduction in number of headache days per week ( from baseline to week 8 )Timepoint: Baseline (Day 0), Week 2, Week 4, Week 6, Week 8. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Headache characteristics: Intensity: Reduction in headache intensity as measured by Visual Analogue Scale (VAS, 0 10).[17,18] .Frequency & Duration: Decrease in frequency and total duration of headache episodes recorded in headache diary. 2. Gastrointestinal symptoms: Change in gastric symptoms (nausea,pain, bloating, dyspepsia) measured by Gastrointestinal Symptom Rating Scale (GSRS). [19,20] 3. Evaluation of hematological and biochemical parameters (CBP, LFT, RFT, CRP) for safety before and after treatment.Timepoint: Baseline (Day 0), Week 2, Week 4, Week 6, Week 8. | — |
Countries
India
Contacts
Public ContactMubeen
Government Nizamia Tibbi College
Outcome results
None listed